Webdisclosure.com

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

07/12/2023 14:30

MASCC (Multinational Association of Supportive Care in Cancer) Webinar on GI Toxicities from Cancer Therapies Made Possible by Grant From Napo Pharmaceuticals, a Jaguar Health Family Company

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

06/12/2023 14:30

Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Website

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

04/12/2023 14:30

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea in Dogs

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

30/11/2023 14:30

Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conference

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

21/11/2023 14:30

Top Line Data for Jaguar Health’s Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Forthcoming

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

14/11/2023 14:00

Jaguar Health Reports Third Quarter 2023 Financial Results

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

10/11/2023 22:15

Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

09/11/2023 14:30

Breast Cancer Related Results of Groundbreaking Napo Pharmaceuticals (a Jaguar Health Family Company) Supported Study on Quality of Life for Cancer Patients and Survivors Accepted for Presentation at the December 2023 San Antonio Breast Cancer Symposium

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

08/11/2023 16:25

Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq's Bid Price Rule

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

08/11/2023 14:30

Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates

Voir tous les communiqués de Jaguar Health, Inc.

1
2
3
4
5
6
7
8
9
10